Do MRI features distinguish Wilson's disease from other early onset extrapyramidal disorders? An analysis of 100

L K Prashanth1, S Sinha, A B Taly

  • 1Department of Neurology, National Institute of Mental Health and Neurosciences, Bangalore, India.

Insights

Magnetic resonance imaging (MRI) can help diagnose Wilson's disease (WD) in early-onset extrapyramidal disorders (EOEPD). Specific MRI findings like the "face of the giant panda" sign and brainstem abnormalities are highly indicative of WD.

Area of Science:

  • Neurology
  • Radiology
  • Medical Imaging

Background:

  • Extrapyramidal disorders (EOEPDs) often require advanced imaging for diagnosis.
  • Wilson's disease (WD) is a treatable genetic disorder that can cause neurological symptoms.
  • Differentiating WD from other EOEPDs using MRI is crucial for timely intervention.

Purpose of the Study:

  • To evaluate the diagnostic value of various MRI features in distinguishing neuropsychiatric Wilson's disease from other early-onset extrapyramidal disorders.
  • To identify specific MRI markers that are pathognomonic for Wilson's disease.

Main Methods:

  • Retrospective analysis of 100 patients (ages 5-40) diagnosed with EOEPD.
  • Review of MRI sequences (T1WI, T2WI, FLAIR) and clinical features.
  • Comparison of MRI findings between 56 patients with WD and 44 patients with other EOEPDs.

Main Results:

  • All 56 WD patients exhibited MRI signal abnormalities, compared to 16 of 44 in the other EOEPD group.
  • Exclusive MRI findings in WD included: "face of the giant panda" sign (14.3%), tectal plate hyperintensity (75%), central pontine myelinolysis (CPM)-like abnormalities (62.5%), and concurrent basal ganglia, thalamus, and brainstem signal changes (55.3%).
  • These specific findings, beyond the "face of the giant panda" sign, are highly suggestive of WD.

Conclusions:

  • MRI is a valuable tool for diagnosing Wilson's disease in the context of EOEPD.
  • Specific MRI patterns, including tectal plate and central pons hyperintensities and simultaneous involvement of basal ganglia, thalamus, and brainstem, are virtually pathognomonic for WD.
  • These findings aid in differentiating WD from other neurological conditions presenting with similar symptoms.